Silver Book Fact

Following the current path, the prostate cancer incidence rate will increase by 75.4% (786,000) between 2003 and 2023. If an alternative path is taken, there will be 21.5% (393,000) fewer prostate cancer cases.

DeVol R, Bedroussian A, Charuworn A, et al. An Unhealthy America: The economic burden of chronic disease. The Milken Institute; October 2007. http://www.milkeninstitute.org/publications/publications.taf?function=detail&ID=38801018&cat=ResRep

Reference

Title
An Unhealthy America: The economic burden of chronic disease
Publisher
The Milken Institute
Publication Date
October 2007
Authors
DeVol R, Bedroussian A, Charuworn A, et al
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Future Value

Related Facts

  • According to the Pharmaceutical Research and Manufacturers of America, a medicine in development targets late-stage metastatic melanoma. The medicine contains a gene encoding antigen that may be able to…  
  • “Among women age 65 and over, the percentage who had a mammogram within the preceding 2 years almost tripled from 23% in 1987 to 64% in 2005.”  
  • Use of an epidermal growth factor inhibitor in the treatment of metastatic colon cancer patients without the KRAS gene mutation saw survival rates of 15.6 months, compared to 5.6 months…  
  • Drugs like bevacizumab- designed to impede the growth of blood vessels and tumors- can cost more than $100,000 per patient.   
  • Investments in cancer care generated $598 billion of additional value for cancer patients diagnosed between 1983 and 1999.